Young-Jin Kim, Paean, Inc. and other investors entered into an agreement to acquire 50% stake in Handok Pharmaceuticals Co., Ltd. (KOSE:A002390) from Hoechst GmbH on September 26, 2012. Young-Jin Kim will acquire 0.696 million shares representing 6% stake in Handok Pharmaceuticals Co., Ltd. as a result of which his stake increases to 14.12%. Paean, Inc. will acquire approximately 3.48 million shares representing 29.99% stake in Handok Pharmaceuticals.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,800 KRW | +1.41% | -9.14% | +10.49% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.49% | 155M | |
+42.68% | 739B | |
+32.34% | 598B | |
-5.95% | 353B | |
+17.36% | 318B | |
+3.30% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+5.87% | 164B |
- Stock Market
- Equities
- A002390 Stock
- News HANDOK Inc.
- Young-Jin Kim, Paean, Inc. and other investors entered into an agreement to acquire 50% stake in Handok Pharmaceuticals Co., Ltd. from Hoechst GmbH.